We found that there were more tumor infiltrating CD8 + T cells in the tumors which were suppressed efficiently by anti-PD-1 and ITK inhibitor combined therapy, when compared to the cells in tumors from all the other treatments (Fig. 1E). This evidence concerns the gene CD8A and neoplasm.